IDP 001
Alternative Names: IDP-001Latest Information Update: 14 Nov 2024
Price :
$50 *
At a glance
- Originator InduPro
- Class Antineoplastics; Bispecific antibodies; Drug conjugates; Immunoconjugates; Immunotherapies; Recombinant fusion proteins
- Mechanism of Action T lymphocyte stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 06 Sep 2024 Preclinical trials in Cancer in USA (unspecified route) (Indupro pipeline, September 2024)